TDAC Announces Share Redemption Results and Extension Vote Outcome
Translational Development Acquisition Company (NYSE: TDAC) reported that only 15% of shares were redeemed by shareholders during the extension vote, leaving $156.8 million in its trust account. The majority voted to extend the SPAC's life following an announced merger with Prologium, a leader in lithium ceramic battery technology.
Topics: merger agreement redemption results shareholder vote SPAC